A molecule already woven into the lives of millions as a treatment for obesity and diabetes has revealed an unexpected dimension: in elderly female mice, semaglutide extended lifespan by roughly 12 percent while sharpening muscle, cognition, and memory. Published in Nature, the finding invites scientists to reconsider whether drugs designed to correct metabolic disorder might also touch the deeper biological currents that govern aging itself. The discovery is real and significant — and it is, for now, a discovery about mice, which is both a beginning and a boundary.